Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurochem ; 132(3): 286-300, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25279950

ABSTRACT

Accumulating evidence indicates that increased intracellular Na(+) concentration ([Na(+) ]i ) in astroglial cells is associated with the development of brain edema under ischemic conditions, but the underlying mechanisms are still elusive. Here, we report that in primary cultured rat cortical astrocytes, elevations of [Na(+) ]i reflecting those achieved during ischemia cause a marked decrease in hypotonicity-evoked current mediated by volume-regulated anion channel (VRAC). Pharmacological manipulations revealed that VRAC inhibition was not due to the reverse mode of the plasma membrane sodium/calcium exchanger. The negative modulation of VRAC was also observed in an astrocytic cell line lacking the predominant astrocyte water channel aquaporin 4, indicating that [Na(+) ]i effect was not mediated by the regulation of aquaporin 4 activity. The inward rectifier Cl(-) current, which is also expressed by cultured astrocytes, was not affected by [Na(+) ]i increase. VRAC depression by high [Na(+) ]i was confirmed in adult astrocytes, suggesting that it was not developmentally regulated. Altogether, these results provide the first evidence that intracellular Na(+) dynamics can modulate astrocytic membrane conductance that controls functional processes linked to cell volume regulation and add further support to the concept that limiting astrocyte intracellular Na(+) accumulation might be a favorable strategy to counteract the development of brain edema.


Subject(s)
Astrocytes/metabolism , Cerebral Cortex/metabolism , Ion Channels/drug effects , Sodium/pharmacology , Animals , Aquaporin 4/metabolism , Astrocytes/drug effects , Cerebral Cortex/cytology , Cerebral Cortex/drug effects , Chloride Channels/metabolism , Female , Male , Patch-Clamp Techniques , Primary Cell Culture , Rats , Rats, Sprague-Dawley , Sodium/metabolism , Sodium-Calcium Exchanger/metabolism
2.
Hum Mol Genet ; 23(19): 5069-86, 2014 Oct 01.
Article in English | MEDLINE | ID: mdl-24824219

ABSTRACT

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a leukodystrophy characterized by myelin vacuolization and caused by mutations in MLC1 or GLIALCAM. Patients with recessive mutations in either MLC1 or GLIALCAM show the same clinical phenotype. It has been shown that GLIALCAM is necessary for the correct targeting of MLC1 to the membrane at cell junctions, but its own localization was independent of MLC1 in vitro. However, recent studies in Mlc1(-/-) mice have shown that GlialCAM is mislocalized in glial cells. In order to investigate whether the relationship between Mlc1 and GlialCAM is species-specific, we first identified MLC-related genes in zebrafish and generated an mlc1(-/-) zebrafish. We have characterized mlc1(-/-) zebrafish both functionally and histologically and compared the phenotype with that of the Mlc1(-/-) mice. In mlc1(-/-) zebrafish, as in Mlc1(-/-) mice, Glialcam is mislocalized. Re-examination of a brain biopsy from an MLC patient indicates that GLIALCAM is also mislocalized in Bergmann glia in the cerebellum. In vitro, impaired localization of GlialCAM was observed in astrocyte cultures from Mlc1(-/-) mouse only in the presence of elevated potassium levels, which mimics neuronal activity. In summary, here we demonstrate an evolutionary conserved role for MLC1 in regulating glial surface levels of GLIALCAM, and this interrelationship explains why patients with mutations in either gene (MLC1 or GLIALCAM) share the same clinical phenotype.


Subject(s)
Cysts/metabolism , Hereditary Central Nervous System Demyelinating Diseases/metabolism , Membrane Proteins/metabolism , Neuroglia/metabolism , Proteins/metabolism , Animals , Animals, Genetically Modified , Astrocytes/metabolism , Brain/metabolism , Brain/pathology , Cell Cycle Proteins , Cell Line , Cell Membrane/metabolism , Cysts/genetics , Disease Models, Animal , Ependyma/cytology , Ependyma/metabolism , Ependyma/ultrastructure , Gene Expression , Genotype , Hereditary Central Nervous System Demyelinating Diseases/genetics , Humans , Intercellular Junctions/metabolism , Intercellular Junctions/ultrastructure , Membrane Proteins/genetics , Mice , Mice, Knockout , Mutation , Phenotype , Protein Transport , Proteins/genetics , Retina/metabolism , Voltage-Dependent Anion Channels/metabolism , Zebrafish/genetics , Zebrafish/metabolism
3.
Article in English | MEDLINE | ID: mdl-20706663

ABSTRACT

Myostatin (MSTN) is a negative modulator of muscle mass. We characterized the horse (Equus caballus) MSTN gene and identified and analysed single nucleotide polymorphisms (SNPs) in breeds of different morphological types. Sequencing of coding, untranslated, intronic, and regulatory regions of MSTN gene in 12 horses from 10 breeds revealed seven SNPs: two in the promoter, four in intron 1, and one in intron 2. The SNPs of the promoter (GQ183900:g.26T>C and GQ183900:g.156T>C, the latter located within a conserved TATA-box like motif) were screened in 396 horses from 16 breeds. The g.26C and the g.156C alleles presented higher frequency in heavy (brachymorphic type) than in light breeds (dolichomorphic type such as Italian Trotter breed). The significant difference of allele frequencies for the SNPs at the promoter and analysis of molecular variance (AMOVA) on haplotypes indicates that these polymorphisms could be associated with variability of morphology traits in horse breeds.


Subject(s)
Horses/genetics , Myostatin/genetics , Analysis of Variance , Animals , Base Sequence , Cattle , Haplotypes , Horses/anatomy & histology , Humans , Mice , Molecular Sequence Data , Phenotype , Polymorphism, Single Nucleotide , Sequence Alignment , Somatotypes , Species Specificity
4.
J Nutr ; 138(8): 1426-31, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18641186

ABSTRACT

Sodium butyrate (SB) is used as an acidifier in animal feed. We hypothesized that supplemental SB impacts gastric morphology and function, depending on the period of SB provision. The effect of SB on the oxyntic and pyloric mucosa was studied in 4 groups of 8 pigs, each supplemented with SB either during the suckling period (d 4-28 of age), after weaning (d 29 to 39-40 of age) or both, or never. We assessed the number of parietal cells immunostained for H+/K+-ATPase, gastric endocrine cells immunostained for chromogranin A and somatostatin (SST) in the oxyntic mucosa, and gastrin-secreting cells in the pyloric mucosa. Gastric muscularis and mucosa thickness were measured. Expressions of the H+/K+-ATPase and SST type 2 receptor (SSTR2) genes in the oxyntic mucosa and of the gastrin gene in the pyloric mucosa were evaluated by real-time RT-PCR. SB increased the number of parietal cells per gland regardless of the period of administration (P < 0.05). SB addition after, but not before, weaning increased the number of enteroendocrine and SST-positive cells (P < 0.01) and tended to increase gastrin mRNA (P = 0.09). There was an interaction between the 2 periods of SB treatment for the expression of H/K-ATPase and SSTR2 genes (P < 0.05). Butyrate intake after weaning increased gastric mucosa thickness (P < 0.05) but not muscularis. SB used orally at a low dose affected gastric morphology and function, presumably in relationship with its action on mucosal maturation and differentiation.


Subject(s)
Butyric Acid/pharmacology , Dietary Supplements , Gastric Mucosa/cytology , Gastric Mucosa/drug effects , Swine/physiology , Animal Feed , Animal Nutritional Physiological Phenomena , Animals , Animals, Suckling , Diet/veterinary , Enteroendocrine Cells/drug effects , Enteroendocrine Cells/metabolism , Gastric Mucosa/metabolism , Gastrins/genetics , Gastrins/metabolism , Gene Expression Regulation/drug effects , H(+)-K(+)-Exchanging ATPase/genetics , H(+)-K(+)-Exchanging ATPase/metabolism , Receptors, Somatostatin/genetics , Receptors, Somatostatin/metabolism , Weaning
5.
Nutrition ; 24(10): 1023-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18562167

ABSTRACT

OBJECTIVE: Our aim was to study the possible synergic action of one prebiotic with increasing dietary doses of a probiotic strain of Bifidobacterium animalis on the translocation of bifidobacteria and on Toll-like receptor (TLR) gene expression in different organs of weaned piglets. METHODS: Sixty-four pigs, reared from 21 to 35 d of age, were fed eight different diets according to a 2 x 4 factorial design: a control diet or the control diet supplemented with three different levels of B. animalis (10(7), 10(9), 10(11) colony-forming units/d), crossed with 0% or 2% sugar beet fructo-oligosaccharides. Pigs were then sacrificed, and the jejunum mucosa, ileocecal lymph nodes, and liver were sampled to determine the presence of Bifidobacterium spp. DNA and to quantify the expression of TLR2-, TLR4-, and tumor necrosis factor-alpha-encoding genes. RESULTS: We found Bifidobacterium spp. genus-specific DNA in lymph nodes of subjects from all dietary treatments, including the control diet, but it increased with the bifidobacteria oral dose (P = 0.065). The linear effect of the dose of B. animalis on the expression of the TLR2-encoding gene in the lymph nodes was observed when fructo-oligosaccharides were added to the diet (P < 0.05). Tumor necrosis factor-alpha-encoding gene expression was positively correlated with TLR4- and TLR2-encoding gene expressions (P < 0.001 and P < 0.01, respectively) and negatively correlated with bifidobacteria DNA (P < 0.05). Moreover, the expression of the TLR4-encoding gene showed a positive correlation with TLR2-encoding gene expression (P < 0.001). In contrast, there was no correlation between expressions of the TLR2- and TLR4-encoding genes with the bifidobacteria DNA. CONCLUSION: Soon after weaning, the translocation of the commensal bacteria in the ileocecal lymph nodes is a physiologic process. Moreover, diet affects the expression of the TLR2-encoding gene.


Subject(s)
Bacterial Translocation/drug effects , Bifidobacterium/growth & development , Oligosaccharides/pharmacology , Probiotics/pharmacology , Toll-Like Receptors/genetics , Animals , Animals, Newborn , Bacterial Translocation/physiology , Colony Count, Microbial , DNA, Bacterial/analysis , Gene Expression Regulation, Bacterial/drug effects , Gene Expression Regulation, Bacterial/genetics , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/genetics , Intestinal Mucosa/microbiology , Liver/microbiology , Lymph Nodes/microbiology , Oligosaccharides/administration & dosage , Probiotics/administration & dosage , Random Allocation , Swine , Toll-Like Receptor 2/biosynthesis , Toll-Like Receptor 2/genetics , Toll-Like Receptor 4/biosynthesis , Toll-Like Receptor 4/genetics , Toll-Like Receptors/biosynthesis , Tumor Necrosis Factor-alpha/metabolism , Weaning
SELECTION OF CITATIONS
SEARCH DETAIL
...